Nature's Miracle Holding Inc. Announces Up to $20 Million Financing with GHS Investment

Nature's Miracle Holding Inc. Announces Up to $20 Million Financing with GHS Investment

ONTARIO, Calif., May 7, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB:NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology, today announced that the Company has entered into an equity purchase financing...

Webull Announces Collaboration with Visa

Webull Announces Collaboration with Visa

With Webull and Visa Direct, users can move money to and from investment accounts in real-time [1] NEW YORK, May 6, 2025 /PRNewswire/ -- Webull (Nasdaq: BULL), an online investment platform, today announced its collaboration with VISA on the Webull...

Caresoft Global Announces Strategic Partnership with KPIT to Drive Leadership in Technology and Cost Optimization Strategies for the Automotive Industry

Caresoft Global Announces Strategic Partnership with KPIT to Drive Leadership in Technology and Cost Optimization Strategies for the Automotive Industry

Caresoft Global's engineering solutions business is to join KPIT, as Caresoft doubles down on technology optimization and cost reduction engineering for the automotive industry. LONDON, May 6, 2025 /PRNewswire/ -- Caresoft Global, a global leader in...

KC Global Media Announces LIV Golf LIVE Broadcast Partnership, Reaching Over 94 Million Homes in More Than 19 Countries Across Asia

KC Global Media Announces LIV Golf LIVE Broadcast Partnership, Reaching Over 94 Million Homes in More Than 19 Countries Across Asia

SINGAPORE, KUALA LUMPUR, Malaysia and TAIPEI, May 2, 2025 /PRNewswire/ -- KC Global Media is excited to announce its LIVE broadcast partnership with LIV Golf, bringing the thrilling action of this season's tournaments to sports fans in more than 94...

Genocury Biotech Annouces Groundbreaking Advance in Relapsed/Refractory DLBCL Through Pioneering In Vivo CD19 CAR-T Therapy

Genocury Biotech Annouces Groundbreaking Advance in Relapsed/Refractory DLBCL Through Pioneering In Vivo CD19 CAR-T Therapy

Genocury launched the in vivo CD19 CAR-T therapy to reach the clinical stage, demonstrating exceptional safety, efficiency and durability. Results are attained without requiring lymphodepletion. SHENZHEN, China, April 30, 2025 /PRNewswire/ --...

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

BOSTON and ROLLE, Switzerland, April 29, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader in data-driven medicine, today announced the expansion of its ongoing collaboration with...

Innovent Announces NMPA Approval of Limertinib, a Third-generation EGFR TKI Collaborated with ASK Pharma, for the First-line Treatment of Lung Cancer

Innovent Announces NMPA Approval of Limertinib, a Third-generation EGFR TKI Collaborated with ASK Pharma, for the First-line Treatment of Lung Cancer

SAN FRANCISCO and SUZHOU,China, April 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...

Baijiayun Announces Plan to Invest Tens of Millions of Dollars Over Five Years to Build New Ecosystem for Autism Rehabilitation

Baijiayun Announces Plan to Invest Tens of Millions of Dollars Over Five Years to Build New Ecosystem for Autism Rehabilitation

BEIJING, April 25, 2025 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution provider, announced a Letter to Investors, in which Baijiayun CEO Mr. Yi Ma stated that following its partnership...

Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Gastrointestinal Cancers

Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Gastrointestinal Cancers

CHENGDU, China, April 25, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") recently announced CM518D1, a CDH17-targeted antibody-drug conjugate (ADC) developed by Keymed, received Investigational New Drug (IND)...

Webull Announces Brand Partnership with Tampa Bay Rays

Webull Announces Brand Partnership with Tampa Bay Rays

ST PETERSBURG, Fla., April 24, 2025 /PRNewswire/ -- Webull (NASDAQ: BULL), an online investment platform, today announced a partnership with the Tampa Bay Rays and the Tampa Bay Rowdies for the 2025 season. Webull will become the Official Online...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • menu
    menu